Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Emmanuel Papadakis's Stock Ratings
Deutsche Bank Analyst
Emmanuel Papadakis is an analyst at Deutsche Bank. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 04/28/2025
Overall Average Return
1.93%
Smart Score
Overall Average Return Percentile
45th
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 09/19/2024 | BNTX | Buy Now | BioNTech | $104.93 | 42.95% | Emmanuel Papadakis52% | $95 → $150 | Maintains | Buy | Get Alert |
| 08/07/2024 | BNTX | Buy Now | BioNTech | $104.93 | -9.46% | Emmanuel Papadakis52% | $95 → $95 | Upgrade | Hold → Buy | Get Alert |
| 08/06/2024 | MRNA | Buy Now | Moderna | $27.40 | 192.01% | Emmanuel Papadakis52% | $85 → $80 | Upgrade | Sell → Hold | Get Alert |
| 03/12/2024 | GRFS | Buy Now | Grifols | $7.15 | — | Emmanuel Papadakis52% | — | Downgrade | Hold → Sell | Get Alert |
| 02/08/2024 | AZN | Buy Now | AstraZeneca | $69.76 | — | Emmanuel Papadakis52% | — | Downgrade | Buy → Hold | Get Alert |
| 11/02/2023 | MRNA | Buy Now | Moderna | $27.40 | — | Emmanuel Papadakis52% | — | Downgrade | Hold → Sell | Get Alert |
| 08/03/2023 | MRNA | Buy Now | Moderna | $27.40 | 356.27% | Emmanuel Papadakis52% | $200 → $125 | Downgrade | Buy → Hold | Get Alert |
| 05/18/2023 | BNTX | Buy Now | BioNTech | $104.93 | 14.36% | Emmanuel Papadakis52% | $135 → $120 | Maintains | Hold | Get Alert |
| 04/24/2023 | BNTX | Buy Now | BioNTech | $104.93 | 28.66% | Emmanuel Papadakis52% | $160 → $135 | Maintains | Hold | Get Alert |
| 03/07/2023 | ALVO | Buy Now | Alvotech | $7.91 | 51.71% | Emmanuel Papadakis52% | $8 → $12 | Maintains | Hold | Get Alert |
| 02/28/2023 | MRNA | Buy Now | Moderna | $27.40 | 630.03% | Emmanuel Papadakis52% | $225 → $200 | Maintains | Buy | Get Alert |
| 11/11/2022 | BNTX | Buy Now | BioNTech | $104.93 | 52.48% | Emmanuel Papadakis52% | $180 → $160 | Maintains | Hold | Get Alert |
| 09/08/2022 | MRNA | Buy Now | Moderna | $27.40 | 502.28% | Emmanuel Papadakis52% | $155 → $165 | Upgrade | Hold → Buy | Get Alert |
| 08/12/2022 | SNY | Buy Now | Sanofi | $52.81 | — | Emmanuel Papadakis52% | — | Upgrade | Sell → Hold | Get Alert |
| 07/01/2022 | ALVO | Buy Now | Alvotech | $7.91 | 26.42% | Emmanuel Papadakis52% | → $10 | Initiates | → Hold | Get Alert |
| 06/01/2022 | BNTX | Buy Now | BioNTech | $104.93 | 71.54% | Emmanuel Papadakis52% | → $180 | Maintains | Hold | Get Alert |
| 04/01/2022 | BNTX | Buy Now | BioNTech | $104.93 | 90.6% | Emmanuel Papadakis52% | → $200 | Maintains | Hold | Get Alert |
| 03/16/2022 | NVO | Buy Now | Novo Nordisk | $62.31 | — | Emmanuel Papadakis52% | — | Upgrade | Hold → Buy | Get Alert |
| 03/07/2022 | MRNA | Buy Now | Moderna | $27.40 | 465.78% | Emmanuel Papadakis52% | $175 → $155 | Maintains | Hold | Get Alert |
| 01/26/2022 | MRNA | Buy Now | Moderna | $27.40 | 538.78% | Emmanuel Papadakis52% | → $175 | Upgrade | Sell → Hold | Get Alert |
| 11/09/2021 | BNTX | Buy Now | BioNTech | $104.93 | 114.43% | Emmanuel Papadakis52% | → $225 | Maintains | Hold | Get Alert |
| 11/05/2021 | GRFS | Buy Now | Grifols | $7.15 | — | Emmanuel Papadakis52% | — | Downgrade | Buy → Hold | Get Alert |
| 10/22/2021 | BNTX | Buy Now | BioNTech | $104.93 | 138.25% | Emmanuel Papadakis52% | → $250 | Initiates | → Hold | Get Alert |
| 10/22/2021 | CVAC | Buy Now | CureVac | $3.42 | 924.89% | Emmanuel Papadakis52% | → $35 | Initiates | → Hold | Get Alert |
| 10/22/2021 | MRNA | Buy Now | Moderna | $27.40 | 812.54% | Emmanuel Papadakis52% | → $250 | Initiates | → Sell | Get Alert |
| 09/20/2021 | NVS | Buy Now | Novartis | $112.86 | — | Emmanuel Papadakis52% | — | Downgrade | Hold → Sell | Get Alert |
| 07/23/2021 | ARGX | Buy Now | argenx | $615.28 | — | Emmanuel Papadakis52% | — | Initiates | → Hold | Get Alert |
| 07/23/2021 | UCBJY | Buy Now | UCB | $85.36 | — | Emmanuel Papadakis52% | — | Initiates | → Buy | Get Alert |
| 07/08/2021 | RHHBY | Buy Now | Roche Holding | $40.49 | — | Emmanuel Papadakis52% | — | Upgrade | Hold → Buy | Get Alert |
| 02/04/2021 | GSK | Buy Now | GSK | $38.09 | — | Emmanuel Papadakis52% | — | Downgrade | Hold → Sell | Get Alert |
| 01/15/2021 | SNY | Buy Now | Sanofi | $52.81 | — | Emmanuel Papadakis52% | — | Initiates | → Sell | Get Alert |
| 01/15/2021 | AZN | Buy Now | AstraZeneca | $69.76 | — | Emmanuel Papadakis52% | — | Initiates | → Buy | Get Alert |
| 01/15/2021 | GSK | Buy Now | GSK | $38.09 | — | Emmanuel Papadakis52% | — | Initiates | → Hold | Get Alert |
| 01/15/2021 | NVS | Buy Now | Novartis | $112.86 | — | Emmanuel Papadakis52% | — | Initiates | → Buy | Get Alert |
| 01/15/2021 | NVO | Buy Now | Novo Nordisk | $62.31 | — | Emmanuel Papadakis52% | — | Initiates | → Buy | Get Alert |
| 06/20/2019 | NVO | Buy Now | Novo Nordisk | $62.31 | — | Emmanuel Papadakis52% | — | Downgrade | Buy → Hold | Get Alert |
| 09/12/2016 | NVO | Buy Now | Novo Nordisk | $62.31 | — | Emmanuel Papadakis52% | — | Upgrade | Hold → Buy | Get Alert |
| 09/14/2015 | AZN | Buy Now | AstraZeneca | $69.76 | — | Emmanuel Papadakis52% | — | Upgrade | Hold → Buy | Get Alert |
| 10/29/2014 | SNY | Buy Now | Sanofi | $52.81 | 47.69% | Emmanuel Papadakis52% | $93 → $78 | Downgrade | Buy → Hold | Get Alert |
| 10/28/2014 | SNY | Buy Now | Sanofi | $52.81 | — | Emmanuel Papadakis52% | — | Downgrade | Buy → Hold | Get Alert |
| 12/17/2013 | GSK | Buy Now | GSK | $38.09 | — | Emmanuel Papadakis52% | — | Downgrade | Buy → Hold | Get Alert |
| 05/28/2013 | GSK | Buy Now | GSK | $38.09 | — | Emmanuel Papadakis52% | — | Upgrade | Hold → Buy | Get Alert |
| 12/12/2012 | NVS | Buy Now | Novartis | $112.86 | — | Emmanuel Papadakis52% | — | Downgrade | Buy → Hold | Get Alert |
